Should the Human Microbiome Be Considered When Developing Vaccines?

1. SekirovI

RussellSL

AntunesLCM

FinlayBB

2010

Gut microbiota in health and disease.

Physiol Rev

90

859

904

2. AbtMC

ArtisD

2009

The intestinal microbiota in health and disease: the influence of microbial products on immune cell homeostasis.

Curr Opin Gastroenterol

25

496

502

3. UmesakiY

SetoyamaH

2000

Structure of the intestinal flora responsible for development of the gut immune system in a rodent model.

Microbes Infect

2

1343

1351

4. BosNA

MeeuwsenCG

WostmannBS

PleasantsJR

BennerR

1988

The influence of exogenous antigenic stimulation on the specificity repertoire of background immunoglobulin-secreting cells of different isotypes.

Cell Immunol

112

371

380

5. Gaboriau-RouthiauV

RakotobeS

LecuyerE

MulderI

LanA

2009

The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses.

Immunity

31

677

689

6. WilsonID

NicholsonJK

2009

The role of gut microbiota in drug response.

Curr Pharm Des

15

1519

1523

7. JohnTJ

1993

Experience with poliovaccines in the control of poliomyelitis in India.

Public Health Rev

21

83

90

8. PatriarcaPA

WrightPF

JohnTJ

1991

Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review.

Rev Infect Dis

13

926

939

9. HanlonP

HanlonL

MarshV

ByassP

ShentonF

1987

Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants.

Lancet

1

1342

1345

10. Suharyono

SimanjuntakC

WithamN

PunjabiN

HeppnerDG

1992

Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children.

Lancet

340

689

694

11. HallanderHO

PaniaguaM

EspinozaF

AskelofP

CorralesE

2002

Calibrated serological techniques demonstrate significant different serum response rates to an oral killed cholera vaccine between Swedish and Nicaraguan children.

Vaccine

21

138

145

12. LagosR

FasanoA

WassermanSS

PradoV

San MartinO

1999

Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR.

J Infect Dis

180

1709

1712

13. WHO

2006

Future needs and directions for Shigella vaccines.

Wkly Epidemiol Rec

81

51

58

14. StrachanDP

1989

Hay fever, hygiene, and household size.

BMJ

299

1259

1260

15. BrisbinJT

GongJ

LustyCA

SabourP

SaneiB

2008

Influence of in-feed virginiamycin on the systemic and mucosal antibody response of chickens.

Poult Sci

87

1995

1999

16. IsolauriE

JoensuuJ

SuomalainenH

LuomalaM

VesikariT

1995

Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG.

Vaccine

13

310

312

17. FangH

ElinaT

HeikkiA

SeppoS

2000

Modulation of humoral immune response through probiotic intake.

FEMS Immunol Med Microbiol

29

47

52

18. de VreseM

RautenbergP

LaueC

KoopmansM

HerremansT

2005

Probiotic bacteria stimulate virus-specific neutralizing antibodies following a booster polio vaccination.

Eur J Nutr

44

406

413

19. PaineauD

CarcanoD

LeyerG

DarquyS

AlyanakianMA

2008

Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial.

FEMS Immunol Med Microbiol

53

107

113

20. WestCE

GotheforsL

GranstromM

KayhtyH

HammarstromML

2008

Effects of feeding probiotics during weaning on infections and antibody responses to diphtheria, tetanus and Hib vaccines.

Pediatr Allergy Immunol

19

53

60

21. KukkonenK

NieminenT

PoussaT

SavilahtiE

KuitunenM

2006

Effect of probiotics on vaccine antibody responses in infancy—a randomized placebo-controlled double-blind trial.

Pediatr Allergy Immunol

17

416

421

22. SohSE

OngDQ

GerezI

ZhangX

ChollateP

2010

Effect of probiotic supplementation in the first 6 months of life on specific antibody responses to infant Hepatitis B vaccination.

Vaccine

28

2577

2579

23. BenyacoubJ

RochatF

SaudanKY

RochatI

AntilleN

2008

Feeding a diet containing a fructooligosaccharide mix can enhance Salmonella vaccine efficacy in mice.

J Nutr

138

123

129

24. VosAP

HaarmanM

BucoA

GoversM

KnolJ

2006

A specific prebiotic oligosaccharide mixture stimulates delayed-type hypersensitivity in a murine influenza vaccination model.

Int Immunopharmacol

6

1277

1286